title: Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity.
abstract: Carbohydrate mimetic peptides are designable, and they can carry T-cell epitopes and circumvent tolerance. A mimic-based human immunodeficiency virus (HIV) vaccine can be a viable alternative to carbohydrate-based antigens if the diversity of epitopes found on gp120 can be recapitulated. To improve existing mimics, an attempt was made to study the structural correlates of the observed polyspecificity of carbohydrate mimetic peptides based on the Y(P/R)Y motif in more detail. A carbohydrate mimetic peptide, D002 (RGGLCYCRYRYCVCVGR), bound a number of lectins with different specificities. Although this peptide reacted strongly with both lotus and concanavalin A (ConA) lectins, it bound to lotus stronger than ConA. By varying the central motif RYRY, five versions were produced in multiple antigen peptide format, and their avidity for lotus and ConA lectins was tested by surface plasmon resonance. Although the kinetic parameters were similar, the version based on the sequence YPYRY had an optimal affinity for both lectins as well as improved avidity for wheat germ agglutinin and phytohemagglutinin. Thus, as far as lectin specificity is concerned, YPYRY had improved multiple antigenic properties. Both RYRY and YPYRY precipitated antibodies from human IgG for intravenous use that bound to gp120 in vitro and immunoprecipitated gp120 from transfected CHO-PI cells. Thus, Y(P/R)Y motifs mimic multiple carbohydrate epitopes, many of which are found on HIV, and preimmune human IgG antibodies that bind to HIV carbohydrates cross-react to a comparable extent with both RYRY and YPYRY carbohydrate mimetic peptides.
authors.affiliation: Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
authors.forename: Anastas D
authors.initials: AD
authors.lastname: Pashov
authors.forename: Jason
authors.initials: J
authors.lastname: Plaxco
authors.forename: Srinivas V
authors.initials: SV
authors.lastname: Kaveri
authors.forename: Behjatolah
authors.initials: B
authors.lastname: Monzavi-Karbassi
authors.forename: Donald
authors.initials: D
authors.lastname: Harn
authors.forename: Thomas
authors.initials: T
authors.lastname: Kieber-Emmons
mesh_terms: D016915:AIDS Vaccines / Q000737:chemistry / Q000276:immunology; D020816:Amino Acid Motifs / Q000276:immunology; D000595:Amino Acid Sequence; D000818:Animals; D001666:Binding Sites, Antibody; D016466:CHO Cells; D002241:Carbohydrates / Q000737:chemistry / Q000276:immunology*; D006224:Cricetinae; D003412:Cricetulus; D003429:Cross Reactions; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry* / Q000276:immunology* / Q000378:metabolism; D015483:HIV Antibodies / Q000378:metabolism; D015488:HIV Antigens / Q000737:chemistry* / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D037102:Lectins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D018716:Molecular Mimicry / Q000276:immunology*; D008969:Molecular Sequence Data
chemical_list: D016915:AIDS Vaccines; D002241:Carbohydrates; D018984:Epitopes, T-Lymphocyte; D015483:HIV Antibodies; D015488:HIV Antigens; D037102:Lectins